Eylea and Salivary gland neoplasm - from FDA reports
There is no Salivary gland neoplasm reported by people who take Eylea yet. This review analyzes which people have Salivary gland neoplasm with Eylea. It is created by eHealthMe based on reports from FDA, and is updated regularly.
What to expect?
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Dec, 16, 2017
No report is found.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Subscribe to the study: get notified of updates to the study.
Do you have Salivary gland neoplasm when taking Eylea?
- Check symptoms - is salivary gland neoplasm caused by a drug or a condition?
- Get alerts to symptoms - forecast your symptoms and get alerts
- Report the side effect - help people in need and in real time
- Ask a question - ask a question related to the study
- write a review - share your experience related to the study
- More tools...
Expand the study to include all drugs with the same ingredientsSalivary gland neoplasm and drugs with ingredients of aflibercept.
Expand the study to include reports from both FDA and eHealthMeSalivary gland neoplasm and Eylea from FDA and eHealthMe reports
Eylea has active ingredients of aflibercept. It is often used in macular degeneration. (latest outcomes from Eylea 6,687 users)
Salivary Gland Neoplasm
Salivary gland neoplasm (tumour of salivary gland) has been reported by people with rheumatoid arthritis, high blood pressure, multiple sclerosis, high blood cholesterol, type 2 diabetes (latest reports from 209 Salivary gland neoplasm patients).